124 related articles for article (PubMed ID: 37014156)
1. MYO1B as a prognostic biomarker and a therapeutic target in Arecoline-associated oral carcinoma.
Sun Z; Guo X; Chen H; Ling J; Zhao H; Chang A; Zhuo X
Mol Carcinog; 2023 Jul; 62(7):920-939. PubMed ID: 37014156
[TBL] [Abstract][Full Text] [Related]
2. Acquisition cancer stemness, mesenchymal transdifferentiation, and chemoresistance properties by chronic exposure of oral epithelial cells to arecoline.
Wang TY; Peng CY; Lee SS; Chou MY; Yu CC; Chang YC
Oncotarget; 2016 Dec; 7(51):84072-84081. PubMed ID: 27557511
[TBL] [Abstract][Full Text] [Related]
3. CCND1-associated ceRNA network reveal the critical pathway of TPRG1-AS1-hsa-miR-363-3p-MYO1B as a prognostic marker for head and neck squamous cell carcinoma.
Li Z; Qiu X; He Q; Fu X; Ji F; Tian X
Sci Rep; 2023 Jul; 13(1):11831. PubMed ID: 37481637
[TBL] [Abstract][Full Text] [Related]
4. Fat mass and obesity-associated protein regulates tumorigenesis of arecoline-promoted human oral carcinoma.
Li X; Xie X; Gu Y; Zhang J; Song J; Cheng X; Gao Y; Ai Y
Cancer Med; 2021 Sep; 10(18):6402-6415. PubMed ID: 34378866
[TBL] [Abstract][Full Text] [Related]
5. Elevated snail expression mediates tumor progression in areca quid chewing-associated oral squamous cell carcinoma via reactive oxygen species.
Lee SS; Tsai CH; Yu CC; Chang YC
PLoS One; 2013; 8(7):e67985. PubMed ID: 23874481
[TBL] [Abstract][Full Text] [Related]
6. Aberrant Myosin 1b Expression Promotes Cell Migration and Lymph Node Metastasis of HNSCC.
Ohmura G; Tsujikawa T; Yaguchi T; Kawamura N; Mikami S; Sugiyama J; Nakamura K; Kobayashi A; Iwata T; Nakano H; Shimada T; Hisa Y; Kawakami Y
Mol Cancer Res; 2015 Apr; 13(4):721-31. PubMed ID: 25421751
[TBL] [Abstract][Full Text] [Related]
7. Arecoline induces epithelial-mesenchymal transformation and promotes metastasis of oral cancer by SAA1 expression.
Ren H; He G; Lu Z; He Q; Li S; Huang Z; Chen Z; Cao C; Wang A
Cancer Sci; 2021 Jun; 112(6):2173-2184. PubMed ID: 33626219
[TBL] [Abstract][Full Text] [Related]
8. Arecoline N-oxide regulates oral squamous cell carcinoma development through NOTCH1 and FAT1 expressions.
Kuo TM; Nithiyanantham S; Lee CP; Hsu HT; Luo SY; Lin YZ; Yeh KT; Ko YC
J Cell Physiol; 2019 Aug; 234(8):13984-13993. PubMed ID: 30624777
[TBL] [Abstract][Full Text] [Related]
9. RNA N6-Methyladenosine (m6A) Methyltransferase-like 3 Facilitates Tumorigenesis and Cisplatin Resistance of Arecoline-Exposed Oral Carcinoma.
Wang C; Kadigamuwa C; Wu S; Gao Y; Chen W; Gu Y; Wang S; Li X
Cells; 2022 Nov; 11(22):. PubMed ID: 36429032
[TBL] [Abstract][Full Text] [Related]
10. β-catenin expression in areca quid chewing-associated oral squamous cell carcinomas and upregulated by arecoline in human oral epithelial cells.
Lee SS; Tsai CH; Tsai LL; Chou MC; Chou MY; Chang YC
J Formos Med Assoc; 2012 Apr; 111(4):194-200. PubMed ID: 22526207
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review of Roles of Arecoline and Arecoline
Ko AM; Tu HP; Ko YC
Cells; 2023 Apr; 12(8):. PubMed ID: 37190117
[TBL] [Abstract][Full Text] [Related]
12. Arecoline arrests cells at prometaphase by deregulating mitotic spindle assembly and spindle assembly checkpoint: implication for carcinogenesis.
Wang YC; Tsai YS; Huang JL; Lee KW; Kuo CC; Wang CS; Huang AM; Chang JY; Jong YJ; Lin CS
Oral Oncol; 2010 Apr; 46(4):255-62. PubMed ID: 20138568
[TBL] [Abstract][Full Text] [Related]
13. ZEB1 as an indicator of tumor recurrence for areca quid chewing-associated oral squamous cell carcinomas.
Ho CM; Hu FW; Lee SS; Shieh TM; Yu CH; Lin SS; Yu CC
J Oral Pathol Med; 2015 Oct; 44(9):693-8. PubMed ID: 25367287
[TBL] [Abstract][Full Text] [Related]
14. Induction of the c-jun protooncogene expression by areca nut extract and arecoline on oral mucosal fibroblasts.
Ho TJ; Chiang CP; Hong CY; Kok SH; Kuo YS; Yen-Ping Kuo M
Oral Oncol; 2000 Sep; 36(5):432-6. PubMed ID: 10964049
[TBL] [Abstract][Full Text] [Related]
15. Elevated Lin28B expression is correlated with lymph node metastasis in oral squamous cell carcinomas.
Lin WT; Shieh TM; Yang LC; Wang TY; Chou MY; Yu CC
J Oral Pathol Med; 2015 Nov; 44(10):823-30. PubMed ID: 25726847
[TBL] [Abstract][Full Text] [Related]
16. Targeting MYO1B impairs tumorigenesis via inhibiting the SNAI2/cyclin D1 signaling in esophageal squamous cell carcinoma.
Li SH; Qian L; Chen YH; Lu HI; Tsai HT; Lyu H; Yang R; Chen CH
J Cell Physiol; 2022 Sep; 237(9):3671-3686. PubMed ID: 35861939
[TBL] [Abstract][Full Text] [Related]
17. Low-dose arecoline regulates distinct core signaling pathways in oral submucous fibrosis and oral squamous cell carcinoma.
Li Z; Fu Y; Hu Y; Zhu Y; Hu L; Shi C; Zhang Y; Zhang J; Zhou S
BMC Oral Health; 2023 Mar; 23(1):171. PubMed ID: 36966276
[TBL] [Abstract][Full Text] [Related]
18. Molecular Mechanisms of Malignant Transformation of Oral Submucous Fibrosis by Different Betel Quid Constituents-Does Fibroblast Senescence Play a Role?
Zhang P; Chua NQE; Dang S; Davis A; Chong KW; Prime SS; Cirillo N
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163557
[TBL] [Abstract][Full Text] [Related]
19. Down-regulation of β-catenin and the associated migration ability by Taiwanin C in arecoline and 4-NQO-induced oral cancer cells via GSK-3β activation.
Hsieh CH; Hsu HH; Shibu MA; Day CH; Bau DT; Ho CC; Lin YM; Chen MC; Wang SH; Huang CY
Mol Carcinog; 2017 Mar; 56(3):1055-1067. PubMed ID: 27648737
[TBL] [Abstract][Full Text] [Related]
20. Passenger strand of miR-145-3p acts as a tumor-suppressor by targeting MYO1B in head and neck squamous cell carcinoma.
Yamada Y; Koshizuka K; Hanazawa T; Kikkawa N; Okato A; Idichi T; Arai T; Sugawara S; Katada K; Okamoto Y; Seki N
Int J Oncol; 2018 Jan; 52(1):166-178. PubMed ID: 29115582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
